In vitro activity and in vivo efficacy against non-tuberculous mycobacteria of SPR719, the active moiety of the novel oral benzimidazole prodrug SPR720
I. A. Critchley, N. Cotroneo, S. Stokes, M. J. Pucci, A. Rubio, K. Hamed
This study evaluates the in vitro activity and in vivo efficacy of SPR720 against non-tuberculous mycobacteria, showing promising results in murine models.
bioRxiv · Dec 8, 2022 · PreprintMicrobiology